| ²é¿´: 1073 | »Ø¸´: 5 | ||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õ߆®ÉO¤Î¾m嘽«ÔùËÍÄú 5 ¸ö½ð±Ò | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
†®ÉO¤Î¾må˜Ð³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
Çó´óÉñÖ¸µ¼Õâ¾ä»°µÄÒâ˼ÓÈÆäÊǾä×ÓÖÐclaim ÒÑÓÐ1È˲ÎÓë
|
|
|
First treatment receipt was defined as the date of first 5-FU/capecitabine claim with no oxaliplatin claim within 30 days (unexposed) or the date of first oxaliplatin claim with or without the presence of 5-FU/capecitabine (exposed). [ ·¢×ÔÊÖ»ú°æ https://muchong.com/3g ] |
» ²ÂÄãϲ»¶
»·¾³¹¤³Ì 085701£¬267Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
275Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
085600 286·Ö ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁÏÓ뻯¹¤272Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ÄϾ©´óѧ»¯Ñ§µ÷¼Á
ÒѾÓÐ9È˻ظ´
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ13È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ6È˻ظ´
085600 ²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
†®ÉO¤Î¾må˜
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 147.5
- Ìû×Ó: 31
- ÔÚÏß: 4Сʱ
- ³æºÅ: 3926899
- ×¢²á: 2015-06-16
3Â¥2015-08-03 18:59:18
tianyayouziz
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 23 (СѧÉú)
- ½ð±Ò: 4311.3
- ºì»¨: 21
- Ìû×Ó: 254
- ÔÚÏß: 53.3Сʱ
- ³æºÅ: 3978353
- ×¢²á: 2015-07-19
- רҵ: »úе¶¯Á¦Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÊÔ´ð£¬ÒÔ½»Á÷ΪĿµÄ£¬¹²Í¬Ñ§Ï°¡£ ÎÄÖÐclaim¿ÉÒÔ´Ó¡°ËßÇó¡±Õâ¸ö±¾ÒâÉÏÑÓÉì³öÀ´£¬ÎÄÖÐËù´«´ïµÄÒâ˼¾ÍÊÇ£º ÒªÇó·þÓÃijijҩÎï¡£·ÒëʱӦÁé»î´¦Àí¡£ È«¾ä£º Ê×´ÎÖÎÁÆ·½°¸Öƶ¨Îª£º Õë¶Ô·Ç±©Â¶×飬30ÌìÄÚ£¬ÔÚ²»·þÓÃoxaliplatinÏ£¬ÒÔµÚÒ»´Î·þÓÃ5-FU/capecitabineÈÕÆÚ¿ªÊ¼£»Õë¶Ô±©Â¶×飬²»ÂÛÊÇ·ñ·þÓÃ5-FU/capecitabine£¬ÒÔµÚÒ»´Î·þÓÃoxaliplatinÈÕÆÚ¿ªÊ¼¡£ |
2Â¥2015-08-03 00:45:21
†®ÉO¤Î¾må˜
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 147.5
- Ìû×Ó: 31
- ÔÚÏß: 4Сʱ
- ³æºÅ: 3926899
- ×¢²á: 2015-06-16
4Â¥2015-08-03 19:33:16
tianyayouziz
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 23 (СѧÉú)
- ½ð±Ò: 4311.3
- ºì»¨: 21
- Ìû×Ó: 254
- ÔÚÏß: 53.3Сʱ
- ³æºÅ: 3978353
- ×¢²á: 2015-07-19
- רҵ: »úе¶¯Á¦Ñ§
5Â¥2015-08-03 21:28:57














»Ø¸´´ËÂ¥
5